LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. LacriJet® has been specifically designed to reduce operating time and trauma for patients, either in the intubation phase as well as for the removal of the device. LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knot and no sutures are needed.
LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.
The LacriJet® is used like a metal probe to facilitate the catheterization between the distal and proximal portions of the canaliculus.
The wound closure and sutures are therefore facilitated. The silicone tube is then released and left in place to avoid future blockage due to scar tissue. At the end of the procedure, it is important to make sure the fixation head is in contact with the punctum to avoid any risk of migration or extrusion of the silicone tube. The fixation plug must be inserted into the punctum with the help of the plug inserter (S1.3090). Once the plug is in place, the collarette should remain flush against the eyelid margin.
• Exclusive new injection system
• Easy to insert and to remove
• Less traumatic
• Available in 7 lengths
• 3 mm plug collarette
• Requires sizer (S1.1288) to select the length & 0.3 mm disposable punctum dilator and plug inserter (S1.3090)
• Sterile, Single use